piperacillin and tazobactam (63323-981)

Drug Facts

Product Profile

Brand Name piperacillin and tazobactam

Generic Name piperacillin and tazobactam

Labeler fresenius kabi usa, llc

Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Routes

INTRAVENOUS

Active Ingredients

piperacillin sodium 2 g/10mL, tazobactam sodium .25 g/10mL

Manufacturer

Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 63323-981

Product ID 63323-981_6487ad37-921c-4994-bef4-38854cdecec9

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA203719

Listing Expiration 2026-12-31

Marketing Start 2018-05-18

Pharmacologic Class

Classes

penicillin-class antibacterial [epc] penicillins [cs] beta lactamase inhibitor [epc] beta lactamase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63323981

Hyphenated Format 63323-981

Supplemental Identifiers

RxCUI

1659131 1659137 1659149

UNII

UXA545ABTT M98T69Q7HP

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name piperacillin and tazobactam (source: ndc)

Generic Name piperacillin and tazobactam (source: ndc)

Application Number ANDA203719 (source: ndc)

Routes

INTRAVENOUS

source: ndc

Resolved Composition

Strengths

2 g/10mL
.25 g/10mL

source: ndc

Packaging

10 VIAL, SINGLE-USE in 1 CARTON (63323-981-53) / 10 mL in 1 VIAL, SINGLE-USE (63323-981-41)

source: ndc

Packages (1)

63323-981-53 10 VIAL, SINGLE-USE in 1 CARTON (63323-981-53) / 10 mL in 1 VIAL, SINGLE-USE (63323-981-41)

Ingredients (2)

piperacillin sodium (2 g/10mL) tazobactam sodium (.25 g/10mL)

Linked Drug Pages (2)

Piperacillin and Tazobactam ndc-match (0.9) Piperacillin and Tazobactam ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["INTRAVENOUS"], "spl_id": "6487ad37-921c-4994-bef4-38854cdecec9", "openfda": {"unii": ["UXA545ABTT", "M98T69Q7HP"], "rxcui": ["1659131", "1659137", "1659149"], "spl_set_id": ["1eb40c84-0cb3-4648-a39f-f4ebc4dbcb16"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-USE in 1 CARTON (63323-981-53)  / 10 mL in 1 VIAL, SINGLE-USE (63323-981-41)", "package_ndc": "63323-981-53", "marketing_start_date": "20180518"}], "brand_name": "Piperacillin and Tazobactam", "product_id": "63323-981_6487ad37-921c-4994-bef4-38854cdecec9", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "63323-981", "generic_name": "Piperacillin and Tazobactam", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin and Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "2 g/10mL"}, {"name": "TAZOBACTAM SODIUM", "strength": ".25 g/10mL"}], "application_number": "ANDA203719", "marketing_category": "ANDA", "marketing_start_date": "20180518", "listing_expiration_date": "20261231"}